Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.
Stephen M. Mason, the CEO of Cardinal Health's GMPD Segment, sold 35,000 shares of the company's stock on August 18, according to an SEC Form 4 filing. The transaction value, as calculated by the weighted average sale price of $236.40, amounted to $8 million. The post-transaction value, based on the market close price of $234.98, was slightly lower at $7.97 million.
Cardinal Health, a global leader in healthcare services and products, reported a trailing twelve-month revenue base of $254.2 billion, with a market capitalization of $55.0 billion. The company's competitive edge stems from its integrated distribution network, substantial scale across pharmaceutical and medical segments, and robust relationships with a wide range of healthcare providers across various regions.
Positioned as a vital component of the healthcare supply chain, Cardinal Health supports the delivery of care in both institutional and individual patient settings.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
